Thrombin is a Na-activated, allosteric serine protease that plays an opposite functional role in blood coagulation. As a protein involved in catalysis at many steps of the coagulation cascade, thrombin activates fibrinogen, converts it to a form that assembles into insoluble fibrin, and further enhances the fibrin strands by activating factor XIII to promote covalent bonding between lysine and glutamine side-chains. Binding of Na is the main driving force behind the procoagulant, prothrombotic and signaling functions of the enzyme. Thrombin can activate platelets by cleaving the N-terminus of protease-activated receptor in their membrane, further promoting the coagulation process. Moreover, thrombin is the key arbiter of this balance due to its dual role and therefore has received utmost attention in structure-function studies and as a target for anticoagulation therapy involved in many diseases associated with coagulation, bleeding, vasoconstriction, etc.
BOC Sciences can provide about 1,300 potential thrombin inhibitors by developing a reliable thrombin serine protease targeted library.
Figure 1. The role of thrombin in blood coagulation and protein C pathways. (Ma, L.; Dorling, A. 2012)
BOC Sciences has established a high-throughput virtual screening technique based on docking approach and molecular fitting method to generate this library:
Figure 2. PAR-1-S1P receptor-mediated signalling in the vascular endothelium. (Ma, L.; Dorling, A. 2012)
BOC Sciences provides professional, rapid and high-quality services of Thrombin Serine Protease Targeted Library design at competitive prices for global customers. Personalized and customized services of Thrombin Serine Protease Targeted Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.